Vincent Jean-Louis
Service des Soins Intensifs, Hôpital Universitaire Erasme, Route de Lennik 808, Brussels B-1070, Belgium.
Crit Care Clin. 2006 Apr;22(2):187-97, v. doi: 10.1016/j.ccc.2006.02.012.
Clinical reports and experimental studies support the beneficial effects of low-dose vasopressin infusions in vasodilatory shock. Before we can recommend vasopressin for routine clinical use in vasodilatory shock, and particularly septic shock, we must await the results of currently ongoing and recently completed randomized clinical trials to ensure that vasopressin does indeed have beneficial effects on organ function and outcome.
临床报告和实验研究支持低剂量血管加压素输注对血管舒张性休克的有益作用。在我们能够推荐血管加压素用于血管舒张性休克,尤其是脓毒性休克的常规临床治疗之前,我们必须等待目前正在进行和最近完成的随机临床试验结果,以确保血管加压素确实对器官功能和预后有有益影响。